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Abstract
Transdermal insulin transport by electroporation was measured using porcine epidermis and fluorescein-labeled insulin. Previous studies
have shown that anionic lipids can enhance the electroporative transport of molecules up to 10 kDa in size. It was also shown that it is the
charge and not the type of the phospholipid head group that influences transdermal transport under electroporation. Moreover, phospholipids
with saturated acyl chains enhance the transport of larger molecules more as compared to those with unsaturated chains. In the current study,
based on those earlier findings, the effect of 1,2-dimyristoyl-3-phosphatidylserine (DMPS) on the transdermal transport of insulin by
electroporation was examined. Porcine epidermis was used as a model for skin. Transport was measured using glass vertical diffusion
apparatus in which the epidermis separated the donor and receiver compartments. Negative pulses were applied across the epidermis using
platinum electrodes. Results show that when electroporation was carried out in the presence of DMPS, there was greater than 20-fold
enhancement of insulin transport. Furthermore, while in the presence of the phospholipid, almost all the transported insulin was detected in
the receiver compartment; in the absence of added lipids, only about half the insulin transported was in the receiver compartment and an
almost equal amount of insulin remained in the epidermis. Fluorescence microscopy revealed that the insulin transport was mainly through
the lipid multilayer regions that surround the corneocytes. D 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
The stratum corneum (SC), the outermost layer of the
skin, is the main barrier to transdermal transport. Electro-
poration has been used to deliver drugs and other mol-
ecules across the skin. The electrical resistance of the SC
is between 5 and 25 kV/cm2 [1] and has an electrical
breakdown potential around 75–100 V [2,3]. Electropora-
tion creates new pathways (pores) resulting in transient
permeabilization of the SC [4,5]. Small molecules like
methylene blue [6] have been successfully transported
into the epidermis/dermis regions by electroporation;
similarly, the transport of metoprolol and fentanyl has
been demonstrated using excised skin mounted between
two compartments [7,8]. The molecular weight cutoff was
determined, using FITC-dextrans, to be around 10 kDa
[9,10]. Enhancement of transport by electroporation has
been attempted using keratolytic molecules (sodium thio-
sulfate, urea, and heparin) with some success [11,12].
Recent studies show that the transports of molecules
across skin were greatly enhanced by anionic lipid for-
mulations [10]. The enhancement of transport occurs
irrespective of the net charge for small ( < 1000 Da)
molecules. In the case of larger molecules (4–10 kDa),
this lipid enhancement of transport is only observed if the
molecules are negatively charged. Insulin having a mono-
meric size of f 6 kDa and two net negative charges (at
normal pH) is a suitable candidate drug for transdermal
delivery. Transdermal insulin delivery has had very
limited success. Previous workers have shown that deliv-
ery of monomeric insulin by iontophoresis is only possi-
ble with pretreatment of the skin by alcohol [13] or by
depilatory cream [14]. According to the authors [13,14],
the pretreatment with alcohol or the depilatory cream is
likely to drastically reduce the barrier property of the skin
thus enabling the transport of insulin. Moreover, the
iontophoresis was carried for 2–3 h. The removal of
the barrier property of the skin and the prolonged treat-
ment time make such an insulin delivery system difficult
and also in addition carries the risk of infection at the
treatment site. When phospholipids are used to enhance
the transport of molecules by electroporation, the skin
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recovers to its original resistive state, that is, its barrier
property is restored in minutes thus reducing the risk of
infection. Furthermore, the treatment time may also be
reduced significantly (minutes) as compared to the 2–3 h
required for iontophoresis [13,14]. The present study is
directed at determining the effect of anionic phospholipids
in enhancing the transdermal transport of insulin by
electroporation.
2. Materials and methods
2.1. Lipid
1,2-Dimyristol-3-phosphatidylserine (DMPS) as chloro-
form solutions was obtained from Avanti Polar Lipids
(Birmingham, AL). The lipids are stored at  80 jC
until used. Lipid dispersions were prepared by first
drying a measured amount of the lipid solution under a
stream of nitrogen and placing the dry lipid under
vacuum for an hour to remove any remaining solvent.
The dry lipid was dispersed by vortexing in Tris buffer
(10 mM Tris–HCl, 150 mM NaCl pH 8.0) at a final
lipid concentration of 2 mg/ml.
2.2. Insulin
FITC-insulin (bovine) was obtained from Sigma-Aldrich
Chemical (St. Louis, MO) as lyophilized powder and stored
at  20 jC. Insulin solution was prepared at a concentration
of 1 Ag/ml in Tris buffer. The insulin solution was stored for
a maximum of 1 week at 4 jC.
2.3. Porcine epidermis
Porcine full-thickness belly skin was obtained fresh from
a local abattoir. Pieces of the skin were heated to 60 jC for 2
min and the epidermis was gently peeled off from the skin.
The fresh epidermis was placed on glass microscope slides
and kept dry at 4 jC until used. Before use, the epidermis
was placed in a dish of distilled water and hydrated for an
hour.
2.4. Electroporation
Insulin transport using electroporation in porcine epider-
mis was carried out using a glass vertical diffusion apparatus
(Crown Glass, Somerville, NJ). A piece of epidermis was
placed between two compartments, one serving as the donor
and the other as the receiver compartment. Both compart-
ments were filled with Tris buffer. The insulin (25 Ag total)
and the lipid dispersion (2 mg/ml) were added to the upper
(donor) compartment. Platinum wire electrodes were placed
close to the epidermis in both the donor and the receiver
compartments. Electroporation was carried out using a pulse
generator (Model 345, Velonex, Santa Clara, CA) delivering
single or multiple unipolar square pulses of 100–105 V (1 ms
pulse width at 1 Hz), with the negative electrode in the
donor compartment.
2.5. Resistance measurements
Pre- and post-pulse epidermis and skin resistance was
measured using the assembly described above. Continuous
low voltage (700 mV, 1 kHz) bipolar square waves were
applied to the epidermis using a Dynascan Model 3300,
pulse generator (Chicago, IL). A load resistor (4.7 kV) was
placed in series with the epidermis, and the voltage drop
across the whole circuit (VO) or just across the skin (VS) was
measured by a recording digital oscilloscope (Fluke 99
Scopemeter Series II, Holland). Skin resistance (in kilo-
ohms) was approximated from the formula
RS ¼ ðVS  RLÞ=ðVO  VSÞ,
where RS = skin resistance and RL= load resistor. A piece of
epidermis was only used if the pre-treatment resistance
equaled 6 kV or more.
2.6. Fluorescence measurement
The amount of FITC-insulin transported across the epi-
dermis to the receiver compartment was measured by remov-
ing the entire content of the receiver and drying to 2.5 ml. The
amount of insulin that was retained in the epidermis was
determined by dissolving the epidermis in Solvablek. Fluo-
rescence intensities were measured in a SLM 8000 Spectro-
fluorimeter (SLM Instruments, Urbana, IL). Excitation and
emission wavelengths were 491 and 517 nm, respectively.
The amount of insulin transported was determined from the
measured fluorescence intensity using a calibration curve
prepared using known amount of FITC-insulin.
2.7. Fluorescence microscopy
The epidermis was viewed using an Olympus IMT-2
microscope with a 20 objective and fluorescence images
recorded with the help of a SPOT digital camera. No
processing was done to enhance the recorded images.
3. Results and discussion
3.1. Insulin transport
The enhancing effect of DMPS on the transport of
insulin was examined by measuring the transport in the
presence and the absence of DMPS (2 mg/ml). The epi-
dermis was pulsed for a total of 10 min. The plot of the total
insulin transported to the receiver compartment in the
presence and the absence of DMPS is shown in Fig. 1.
When the epidermis is electroporated for 10 min in the
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absence of DMPS, with insulin in the donor compartment,
there is very little transport of the drug to the receiver
compartment ( < 0.6 Ag/cm2 total) (Fig. 1A). When DMPS
was added together with the insulin, the total insulin trans-
port in the receiver compartment was around f 13 Ag/cm2
(Fig. 1A). The enhancement in insulin transport is thus
around 20-fold. The enhancement in transport due to added
mixed phospholipids (containing an anionic phospholipid
DOPG and DOPC at1:1 molar ratio) observed for different
molecular-weight Dextrans shows a size dependence and
the enhancement is f 15-fold for a 4-kDa Dextran [8]. The
anionic lipid-mediated transport enhancement can be as
high as 80-fold (4 kDa Dextrans) with added DMPS [15].
Almost all of the insulin transported by electroporation in
the presence of DMPS is found in the receiver compart-
ment, while only about 50% of it is in the receiver compart-
ment if the lipid was not added during electroporation (Fig.
1B). The other half of the insulin transported was retained
in the epidermis. However, because of the large amount of
insulin transport in the presence of added lipid, the actual
amount of insulin in the epidermis is greater in the presence
of DMPS.
3.2. Fluorescence imaging
The FITC-insulin retained in the epidermis after electro-
poration can be observed by fluorescence microscopy (Fig.
Fig. 2. Fluorescence photomicrographs of porcine epidermis after transport
of FITC-labeled insulin under electroporation with (A) and without (B)
added DMPS. The illumination and the exposure were the same in both
photomicrographs. The bright fluorescence from the FITC label on the
insulin is seen around the corneocytes. Scale bar represents 50 Am.
Fig. 1. Transdermal insulin transport under electroporation with and without
added DMPS (2 mg/ml) using 100 V negative pulse (at 1 Hz and 1 ms pulse
width) (A) for 10 min, and the percentage of the total insulin transported
that is in the compartment under those conditions (B). The rest of the
insulin remained in the epidermis.
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2A,B). Most of the fluorescence is seen in the lipid
multilayers around the corneocytes indicating that the
transport route is primarily through these regions of the
epidermis. The images obtained from epidermis in which
the electroporation was conducted in the presence and the
absence of DMPS show a similar distribution of the FITC-
insulin. This supports our earlier observation that the
localized transport regions are primarily in the lipid regions
of the epidermis.
Anionic phospholipids have recently been shown to
enhance the transdermal transport of molecules during
electroporation [10]. The enhancement is dependent upon
the charge and the size of the delivered molecule. The
anionic lipid-mediated enhancement is small if the trans-
ported molecule is small and negatively charged, and the
enhancement is large for positively or uncharged small
molecules [10]. However, in the case of larger molecules
(MWg4 kDa), the enhancement is greater for negatively
charged molecules. There is very little, or no enhancement
due to added anionic lipids observed for large uncharged or
positively charged molecules [10] under electroporation.
Anionic phospholipids with saturated acyl chains were
found to enhance transport much more than the same
phospholipid with unsaturated acyl chains [15]. DMPS
(1 mg/ml) was found to enhance the transport of 4-kDa and
9-kDa Dextrans by 80- and 90-fold, respectively [15]. The
enhancement found here for FITC-insulin is around 20-fold,
which is less than that found for 9-kDa dextrans. The
monomeric molecular weight of insulin is around 6 kDa
and if it had the same charge/mass ratio as that for the
Dextrans used in the earlier work, one would expect the
DMPS-induced enhancement would have been greater.
There are two possible reasons for the lower enhancement
of transport for insulin in the presence of added anionic
lipids. The first is that insulin carries only two net negative
charges per molecule. The charge on the Dextrans used is
greater. (The exact charge to mass ratio of the Dextrans used
is not known. The Dextrans are labeled with between 0.003
to 0.02 mol FITC per mole glucose.) The second possibility
is that while the monomeric size of insulin is 6 kDa, it is
known to form dimers and hexamers (in presence of
zinc)[16,17]. The resultant size of insulin would thus
increase to 12 or 36 kDa dependent upon the presence of
zinc. Since no effort was made to ensure that the product
used was zinc-free, it is expected that a large majority of the
insulin would be in a hexameric state. An enhancement of
20-fold in transport by electroporation seen with added
DMPS is thus in the range expected from the earlier studies
with dextrans. The results indicate that if monomeric insulin
were used, it would be possible to deliver very much greater
amounts of insulin by transdermal electroporation. Thera-
peutic levels of insulin delivery are thus very likely using
phospholipid-enhanced electroporation.
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